Medical Developments International Limited [ASX:MVP] share price and news 2022

Company Description

Medical Developments International Limited (MVP) is an Australia-based company delivering emergency medical solutions dedicated to improving patient outcomes. MVP is into emergency pain relief and respiratory products. The Company manufactures Penthrox, a fast-acting trauma & emergency pain relief product. MVP is expanding internationally and manufactures a range of Asthma respiratory devices.

Medical Developments International Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.medicaldev.com.

This a small cap company with market cap of 401 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is greater than both sector and market.

Earnings PE PB PE growth
Company 3 0 8.54 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how mvp dividend grows in the recent years.Medical Developments International Limited has dividend yield of 0.37%